Research team lead by Toyohashi University of Technology have proposed a new drug to treat tuberculosis. This drug may inhibit the cell division of Mycobacterium tuberculosis (M. tuberculosis) and suppress its growth. In addition, because this drug acts on the enzymes secreted by M. tuberculosis, M. tuberculosis has very little chance of mutation and develops no drug resistance. Therefore, it's expected this drug will lead to a novel drug that will keep its effectiveness.
